medroxyprogesterone acetate has been researched along with Flushing in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (28.57) | 18.7374 |
| 1990's | 2 (28.57) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bergqvist, A; Carson, SA; Luciano, A; Ross, D; Schlaff, WD | 1 |
| Christiansen, C; Marslew, U; Munk-Nielsen, N; Nilas, L; Riis, BJ | 1 |
| Jaszczak, P; Planellas, J; Poulsen, HK; Saure, A | 1 |
| Bachmann, G; Pickar, JH; Pinkerton, JV; Shoupe, D; Utian, WH | 1 |
| Cedars, MI; Judd, HL; Lu, JK; Meldrum, DR | 1 |
| Charig, CR; Rundle, JS | 1 |
| Presl, J | 1 |
4 trial(s) available for medroxyprogesterone acetate and Flushing
| Article | Year |
|---|---|
Subcutaneous injection of depot medroxyprogesterone acetate compared with leuprolide acetate in the treatment of endometriosis-associated pain.
Topics: Adult; Bone Density; Delayed-Action Preparations; Endometriosis; Estrogens; Female; Flushing; Humans; Injections, Subcutaneous; Leuprolide; Medroxyprogesterone Acetate; Pain; Palliative Care; Quality of Life; Single-Blind Method; Treatment Outcome; Uterine Hemorrhage | 2006 |
Bleeding pattern and climacteric symptoms during different sequential combined HRT regimens in current use.
Topics: Breast; Climacteric; Desogestrel; Drug Administration Schedule; Drug Therapy, Combination; Estradiol; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Flushing; Humans; Levonorgestrel; Medroxyprogesterone Acetate; Menstrual Cycle; Middle Aged; Norethindrone; Norethindrone Acetate; Progesterone Congeners | 1994 |
A double-blind, randomized, comparative study evaluating clinical effects of two sequential estradiol-progestogen combinations containing either desogestrel or medroxyprogesterone acetate in climacteric women.
Topics: Administration, Oral; Blood Pressure; Climacteric; Desogestrel; Double-Blind Method; Estradiol; Estrogens, Conjugated (USP); Female; Flushing; Hormone Replacement Therapy; Humans; Medroxyprogesterone Acetate; Menopause; Middle Aged; Mood Disorders; Placebos; Progesterone Congeners; Sweating; Uterine Hemorrhage | 2000 |
Relief of vasomotor symptoms and vaginal atrophy with lower doses of conjugated equine estrogens and medroxyprogesterone acetate.
Topics: Adult; Animals; Atrophy; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Estrogens, Conjugated (USP); Female; Flushing; Horses; Humans; Incidence; Medroxyprogesterone Acetate; Middle Aged; Progesterone Congeners; Severity of Illness Index; Vagina | 2001 |
3 other study(ies) available for medroxyprogesterone acetate and Flushing
| Article | Year |
|---|---|
Treatment of endometriosis with a long-acting gonadotropin-releasing hormone agonist plus medroxyprogesterone acetate.
Topics: Adult; Drug Therapy, Combination; Endometriosis; Estradiol; Estrone; Female; Flushing; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Humans; Luteinizing Hormone; Medroxyprogesterone; Medroxyprogesterone Acetate; Pain; Pelvic Neoplasms | 1990 |
Flushing. Long-term side effect of orchiectomy in treatment of prostatic carcinoma.
Topics: Aged; Aged, 80 and over; Flushing; Follicle Stimulating Hormone; Humans; Hydroxyindoleacetic Acid; Luteinizing Hormone; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Orchiectomy; Pilot Projects; Prolactin; Prostatic Neoplasms; Vanilmandelic Acid | 1989 |
[Medroxyprogesterone-acetate in gynecologic endocrinology].
Topics: Chemical Phenomena; Chemistry; Climacteric; Female; Flushing; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Menstruation Disturbances | 1987 |